Challenges of Cell Counting in Cell Therapy Products

Overview

Journal Cell Transplant

Specialties Cell Biology
General Surgery

Date 2024 Oct 28

PMID 39462979

Authors

Muyun Liu

Wanglong Chu

Tao Guo

Xiuping Zeng

Yan Shangguan

Fangtao He

Xiao Liang

Affiliations

Soon will be listed here.

Abstract

Cell counting is a common and fundamental cell measurement technique that plays a crucial role in the development and quality control of cell therapy products. However, accurate and reliable cell counting can be challenging owing to the complexity of cell preparations, diverse counting purposes, and various counting methods. This review summarizes the challenges encountered in cell counting for cell therapy products and provides strategies to improve the cell counting accuracy, thereby guiding the counting process and ensuring the quality of cell therapy products.

References

Chong E, Levine B, Grupp S, Davis M, Siegel D, Maude S . CAR T cell viability release testing and clinical outcomes: is there a lower limit?. Blood. 2019; 134(21):1873-1875. PMC: 6872962. DOI: 10.1182/blood.2019002258. View

Wang L, Janes M, Kumbhojkar N, Kapate N, Clegg J, Prakash S . Cell therapies in the clinic. Bioeng Transl Med. 2021; 6(2):e10214. PMC: 8126820. DOI: 10.1002/btm2.10214. View

Sarkar S, Lund S, Vyzasatya R, Vanguri P, Elliott J, Plant A . Evaluating the quality of a cell counting measurement process via a dilution series experimental design. Cytotherapy. 2017; 19(12):1509-1521. DOI: 10.1016/j.jcyt.2017.08.014. View

Oberschmidt O, Morgan M, Huppert V, Kessler J, Gardlowski T, Matthies N . Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering. Hum Gene Ther Methods. 2019; 30(3):102-120. PMC: 6590729. DOI: 10.1089/hgtb.2019.039. View

Aussel C, Busson E, Vantomme H, Peltzer J, Martinaud C . Quality assessment of a serum and xenofree medium for the expansion of human GMP-grade mesenchymal stromal cells. PeerJ. 2022; 10:e13391. PMC: 9161815. DOI: 10.7717/peerj.13391. View

Pierce L, Anderson H, Sarkar S, Bauer S, Sarkar S . Experimental and computational approach to establish fit-for-purpose cell viability assays. Regen Med. 2024; 19(1):27-45. DOI: 10.2217/rme-2023-0154. View

Richards C, Sarkar S, Kandell J, Snyder R, Lakshmipathy U . Assessing the suitability of cell counting methods during different stages of a cell processing workflow using an ISO 20391-2 guided study design and analysis. Front Bioeng Biotechnol. 2023; 11:1223227. PMC: 10438949. DOI: 10.3389/fbioe.2023.1223227. View

Ballikaya S, Sadeghi S, Niebergall-Roth E, Nimtz L, Frindert J, Norrick A . Process data of allogeneic ex vivo-expanded ABCB5 mesenchymal stromal cells for human use: off-the-shelf GMP-manufactured donor-independent ATMP. Stem Cell Res Ther. 2020; 11(1):482. PMC: 7667860. DOI: 10.1186/s13287-020-01987-y. View

Tristan-Manzano M, Maldonado-Perez N, Justicia-Lirio P, Munoz P, Cortijo-Gutierrez M, Pavlovic K . Physiological lentiviral vectors for the generation of improved CAR-T cells. Mol Ther Oncolytics. 2022; 25:335-349. PMC: 9163403. DOI: 10.1016/j.omto.2022.05.003. View

10.

Kumar P, Nagarajan A, Uchil P . Analysis of Cell Viability by the Lactate Dehydrogenase Assay. Cold Spring Harb Protoc. 2018; 2018(6). DOI: 10.1101/pdb.prot095497. View

11.

Chan L, McCulley K, Kessel S . Assessment of Cell Viability with Single-, Dual-, and Multi-Staining Methods Using Image Cytometry. Methods Mol Biol. 2017; 1601:27-41. DOI: 10.1007/978-1-4939-6960-9_3. View

12.

Baust J, Gao D, Baust J . Cryopreservation: An emerging paradigm change. Organogenesis. 2010; 5(3):90-6. PMC: 2781087. DOI: 10.4161/org.5.3.10021. View

13.

Hare J, Traverse J, Henry T, Dib N, Strumpf R, Schulman S . A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009; 54(24):2277-86. PMC: 3580848. DOI: 10.1016/j.jacc.2009.06.055. View

14.

Huang Y, Watkins R, Patel S, Pierce M, Franco Nitta C, Qazi H . Practical Characterization Strategies for Comparison, Qualification, and Selection of Cell Viability Detection Methods for Cellular Therapeutic Product Development and Manufacturing. J Fluoresc. 2023; 34(5):2263-2278. DOI: 10.1007/s10895-023-03382-1. View

15.

Chan L, Laverty D, Smith T, Nejad P, Hei H, Gandhi R . Accurate measurement of peripheral blood mononuclear cell concentration using image cytometry to eliminate RBC-induced counting error. J Immunol Methods. 2012; 388(1-2):25-32. DOI: 10.1016/j.jim.2012.11.010. View

16.

Hunt C . Technical Considerations in the Freezing, Low-Temperature Storage and Thawing of Stem Cells for Cellular Therapies. Transfus Med Hemother. 2019; 46(3):134-150. PMC: 6558338. DOI: 10.1159/000497289. View

17.

Liao N, Su L, Cao Y, Qiu L, Xie R, Peng F . Tracking Cell Viability for Adipose-Derived Mesenchymal Stem Cell-Based Therapy by Quantitative Fluorescence Imaging in the Second Near-Infrared Window. ACS Nano. 2022; 16(2):2889-2900. DOI: 10.1021/acsnano.1c09960. View

18.

Gagliardi C, Khalil M, Foster A . Streamlined production of genetically modified T cells with activation, transduction and expansion in closed-system G-Rex bioreactors. Cytotherapy. 2019; 21(12):1246-1257. DOI: 10.1016/j.jcyt.2019.10.006. View

19.

Babakhanova G, Zimmerman S, Pierce L, Sarkar S, Schaub N, Simon Jr C . Quantitative, traceable determination of cell viability using absorbance microscopy. PLoS One. 2022; 17(1):e0262119. PMC: 8769294. DOI: 10.1371/journal.pone.0262119. View

20.

Louis K, Siegel A . Cell viability analysis using trypan blue: manual and automated methods. Methods Mol Biol. 2011; 740:7-12. DOI: 10.1007/978-1-61779-108-6_2. View